ATE452544T1 - Verwendung von negativ geladene, unverdauliche polysaccharidenhydrolysate zur verringerung des transports durch dichte verbindungsstellen des darms - Google Patents

Verwendung von negativ geladene, unverdauliche polysaccharidenhydrolysate zur verringerung des transports durch dichte verbindungsstellen des darms

Info

Publication number
ATE452544T1
ATE452544T1 AT00914366T AT00914366T ATE452544T1 AT E452544 T1 ATE452544 T1 AT E452544T1 AT 00914366 T AT00914366 T AT 00914366T AT 00914366 T AT00914366 T AT 00914366T AT E452544 T1 ATE452544 T1 AT E452544T1
Authority
AT
Austria
Prior art keywords
molecular weight
intestinal
allergens
microorganisms
reduce transport
Prior art date
Application number
AT00914366T
Other languages
English (en)
Inventor
Pieter Bijlsma
Jacques Groot
Johannes Timmermans
Der Meulen Jan Van
Amanda Kiliaan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE452544T1 publication Critical patent/ATE452544T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/273—Dextran; Polysaccharides produced by leuconostoc
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
AT00914366T 1999-03-26 2000-03-21 Verwendung von negativ geladene, unverdauliche polysaccharidenhydrolysate zur verringerung des transports durch dichte verbindungsstellen des darms ATE452544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1011680A NL1011680C2 (nl) 1999-03-26 1999-03-26 Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
PCT/NL2000/000187 WO2000057727A1 (en) 1999-03-26 2000-03-21 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions

Publications (1)

Publication Number Publication Date
ATE452544T1 true ATE452544T1 (de) 2010-01-15

Family

ID=19768924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00914366T ATE452544T1 (de) 1999-03-26 2000-03-21 Verwendung von negativ geladene, unverdauliche polysaccharidenhydrolysate zur verringerung des transports durch dichte verbindungsstellen des darms

Country Status (13)

Country Link
US (1) US6686341B1 (de)
EP (1) EP1164874B1 (de)
JP (1) JP2002539809A (de)
CN (1) CN100448451C (de)
AT (1) ATE452544T1 (de)
AU (1) AU3575500A (de)
DE (1) DE60043579D1 (de)
DK (1) DK1164874T3 (de)
ES (1) ES2338747T3 (de)
HK (1) HK1042833B (de)
NL (1) NL1011680C2 (de)
PT (1) PT1164874E (de)
WO (1) WO2000057727A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001069238A2 (en) * 2000-03-13 2001-09-20 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Intestinal uptake of macromolecules
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
EP1485074A2 (de) 2002-03-15 2004-12-15 Rytek Zusammensetzungen zur behandlung von magendarm funktionellen störungen
AU2003236239A1 (en) * 2002-04-17 2003-10-27 Takara Bio Inc. Remedies
EP1551852A4 (de) * 2002-04-25 2007-03-21 Momenta Pharmaceuticals Inc Verfahren und produkte zur verabreichung an die schleimhaut
JP2004107316A (ja) * 2002-07-23 2004-04-08 Meiji Milk Prod Co Ltd リン酸化デキストラン
EP2070551B1 (de) 2003-01-31 2013-01-16 Simply Thick LLC Verfahren zur Herstellung von verdickten Getränken für Dysphagia
PT1721612E (pt) * 2003-10-24 2009-09-02 Nutricia Nv Oligossacarídeos imunomoduladores
JP4728572B2 (ja) * 2003-11-11 2011-07-20 国立大学法人広島大学 アレルギー体質改善剤
KR20060127874A (ko) * 2003-12-12 2006-12-13 타이요 카가꾸 가부시키가이샤 장질환 개선용 조성물
WO2006088491A2 (en) * 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
DE102005001252A1 (de) 2005-01-11 2006-08-17 Jobes Vital Gmbh Zusammensetzung zur Behandlung der Apnoe, des Schnarchens und von Schlafstörungen
WO2007019554A2 (en) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides for delivery of active agents
CA2685208C (en) * 2007-04-24 2014-04-08 Novelmed Therapeutics, Inc. Methods and compositions of inhibiting complement and cellular activation with dextran sulfate
US8445044B2 (en) * 2007-05-07 2013-05-21 Kent Precision Foods Group, Inc. Food thickening agent, method for producing food thickening agent
WO2013017905A1 (en) * 2011-08-04 2013-02-07 Compagnie Gervais Danone Composition comprising gellan gum, buttermilk and lactic acid bacteria process of making the same
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
DK3319616T3 (da) * 2015-07-10 2021-10-18 Nutrition Sciences Nv Pektinsammensætninger til at forebygge og behandle inflammatoriske sygdomme
JP2018521172A (ja) * 2015-07-10 2018-08-02 ディーエスエム アイピー アセッツ ビー．ブイ． 炎症性疾患の予防および治療用の食料および／または飼料組成物
CN109793751B (zh) * 2019-01-15 2021-02-26 广西壮族自治区中国科学院广西植物研究所 阿拉伯木聚糖磺酸盐在制备治疗骨关节炎的药物中的应用
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834684A (en) 1954-06-17 1958-05-13 Midland Chemical Corp Stabilized bodied milk and frozen milk products comprising carboxymethyl dextran
US2813797A (en) * 1954-07-13 1957-11-19 Midland Chemical Corp Thickened fruit compositions comprising carboxymethyl dextran
GB8402573D0 (en) * 1984-02-01 1984-03-07 Fisons Plc Oral formulation
US4877634A (en) * 1987-07-01 1989-10-31 Microlife Technics, Inc. Food product containing novel dried compositions with polysaccharides
DK0483070T3 (da) * 1990-10-24 1995-07-17 Sandoz Nutrition Ltd Næringsmæssigt komplet fødevaresammensætning indeholdende hydrolyseret opløselig fiber
JP3029887B2 (ja) * 1991-03-08 2000-04-10 日本製粉株式会社 カゼインホスホペプチド含有食品
US5616570A (en) * 1991-10-18 1997-04-01 Lange, Iii; Louis G. Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
US5514665A (en) 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
SE9402531L (sv) 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE9402529D0 (sv) 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel
JP3240102B2 (ja) 1994-08-11 2001-12-17 江崎グリコ株式会社 リン酸化糖とその製造方法
WO1996024362A1 (fr) 1995-02-07 1996-08-15 Shiseido Company, Ltd. Agents anti-inflammatoires
US5658893A (en) 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
CA2251129A1 (en) 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides

Also Published As

Publication number Publication date
HK1042833A1 (en) 2002-08-30
CN1345189A (zh) 2002-04-17
US6686341B1 (en) 2004-02-03
PT1164874E (pt) 2010-03-22
JP2002539809A (ja) 2002-11-26
CN100448451C (zh) 2009-01-07
EP1164874B1 (de) 2009-12-23
EP1164874A1 (de) 2002-01-02
HK1042833B (zh) 2010-02-26
DK1164874T3 (da) 2010-03-01
EP1164874A4 (de) 2002-04-08
NL1011680C2 (nl) 2000-09-27
WO2000057727A1 (en) 2000-10-05
AU3575500A (en) 2000-10-16
DE60043579D1 (de) 2010-02-04
ES2338747T3 (es) 2010-05-12

Similar Documents

Publication Publication Date Title
ATE452544T1 (de) Verwendung von negativ geladene, unverdauliche polysaccharidenhydrolysate zur verringerung des transports durch dichte verbindungsstellen des darms
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
ATE230994T1 (de) Methode zur behandlung androgenbedingter krankheiten
MX337528B (es) Composición inmunogénica que comprende un sacárido capsular estafilocócico o-acetilado y una proteína estafilocócica.
MX339658B (es) Combinaciones y metodos para administracion subcutanea de inmunoglobulina y hialuronidasa.
ATE279865T1 (de) Ernährungszusammensetzungen enthaltend unverdauliche polysaccharide und ihre verwendung zur verminderung des transports durch dichte verbindungsstellen
BR112022018645A2 (pt) Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide
EP2298360A3 (de) Verfahren und immunmodulierende Nukleinsäurekomponenten zur Vorbeugung und Behandlung von Krankheiten
DK1387620T3 (da) Fremgangsmåde til fremstilling af et næringsadditiv, et additiv samt anvendelse deraf
ATE357241T1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
UA97359C2 (en) Immunogenic composition
PL1603544T3 (pl) Leczenie stanów żołądkowo-jelitowych za pomocą N-2,3,3-tertametylobicyklo2.2.1 heptano-2-aminy
Vetvicka et al. Role of β-glucan in biology of gastrointestinal tract
ATE374620T1 (de) Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen
BR0108096A (pt) Método para manter ou melhorar a sìntese de mucinas
DE602004022427D1 (de) Zusammensetzungen basierend auf T-4 Immunstimulierender-Faktor ("TISF") zur Behandlung von Mangel and roten Blutkörperchen, Granulocyten un Blutplättchen
EA202192330A1 (ru) Олигонуклеотиды, препятствующие экспрессии белка, ассоциированного с синдромом ломкой х-хромосомы, и способы их применения
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina
ATE443763T1 (de) Behandlungs- und prophylaxeverfahren
WO2005030985A3 (en) Use of amino acid sequences involved in the elongation of fatty acids in identifying and/or developing compounds for preventing and/or treating metabolic diseases
TH133385B (th) องค์ประกอบทางโภชนาการที่รวมถึงแฟตตี้ชนิดมีกิ่งเพื่อปรับปรุงการทำงานเป็นสิ่งกีดขวางของลำไส้

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1164874

Country of ref document: EP